logo

Syndax Pharma (SNDX)



Trade SNDX now with
  Date
  Headline
12/3/2018 10:08:27 AM Syndax Pharmaceuticals Announces Presentation Of Preclinical Data From Menin-MLL Program
11/5/2018 4:15:06 PM Syndax Pharmaceuticals Q3 Loss/share $0.68, Same As Last Year
5/30/2018 4:06:03 PM Syndax And Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
5/17/2018 7:13:14 AM Syndax Announces Updated Results From Phase 2 ENCORE 601 Trial Of Entinostat In Combination With KEYTRUDA
1/10/2018 7:04:23 AM Syndax Says Clinical Collaboration To Evaluate Entinostat In Combination With Anti-PD-L1 Cancer Immunotherapy
1/5/2018 1:22:41 PM B. Riley FBR Starts Syndax Pharma (SNDX) At Buy With $40.00 Price Target
3/16/2017 8:55:28 AM FBR Capital Markets Starts Syndax Pharma (SNDX) At Outperform With $27 Price Target